Landscapes / Targets

DLL3

15 drugs act on DLL3, in 55 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs15

DrugHow it worksCompanyStageNext dateDetails
Monoclonal antibody
Amgen · Public AMGN
Approved 24 Sep 2027Phase 3 trial completes
—
Phase 3 Apr 2027Phase 1/2 trial completes
Multi-specific immunoglobulin
Phase 3 17 Dec 2027Phase 2 trial completes
Multi-specific immunoglobulin
Merck & Co. · Public MRK
Phase 3 28 Jan 2028Phase 1/2 trial completes
—
Phase 1/2 14 Feb 2027Phase 1/2 trial completes
Multi-specific immunoglobulin
Phase 1/2 Dec 2027Phase 1/2 trial completes
—
Phase 1/2 Sep 2028Phase 1/2 trial completes
—
Phase 1/2 Jul 2029Phase 1/2 trial completes
—
Phase 1/2 3 Mar 2031Phase 1/2 trial completes
Multi-specific immunoglobulin
AbbVie · Public ABBV
Phase 2 Dec 2031Phase 2 trial completes
—
Phase 1 1 Dec 2027Phase 1 trial completes
—
Phase 1 Dec 2027Phase 1 trial completes
—
Phase 1 Mar 2028Phase 1 trial completes
—
Phase 1 29 Aug 2031Phase 1 trial completes
—
Phase 1 —

About this list

Checked
15 of 15 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow DLL3

Following is part of Solo: you see every change to DLL3 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in